🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 39 of 200 · A–Z by INN

  1. chlorzoxazone

    CHLORZOXAZONE Teva Pharma GmbH

    ORAL FDA: approved

  2. cho-

    NMPA: clinical trials

  3. cholera vaccine (inactivated, oral)

    DUKORAL

    EMA: approved

    J07AE01

  4. cholera vaccine, oral, live

    VAXCHORA

    EMA: approved

    J07AE02

  5. cholestyramine

    CHOLESTYRAMINE Teva Pharma GmbH

    ORAL FDA: approved

  6. cholic acid

    ORPHACOL Mirum Pharmaceuticals International B.V.

    ORAL FDA: approved · EMA: approved

    A05AA03

  7. choline c-11

    CHOLINE C-11

    INTRAVENOUS FDA: approved

  8. choline fenofibrate

    FENOFIBRIC ACID

    ORAL FDA: approved

  9. chop

    NMPA: clinical trials

  10. choriogonadotropin alfa

    OVIDREL Merck KGaA, Darmstadt, Germany

    INJECTION FDA: approved · EMA: approved · TGA: approved

    G03GA08

  11. chromic chloride

    CHROMIC CHLORIDE

    INJECTION FDA: approved

  12. chromic phosphate p-32

    PHOSPHOCOL P32

    INJECTION FDA: approved

  13. chs-

    NMPA: clinical trials

  14. chymopapain

    CHYMODIACTIN Disc Medicine

    INJECTION FDA: approved

  15. ciclesonide

    ALVESCO 160 Chiesi Australia Pty Ltd

    NASAL FDA: approved · TGA: approved

  16. ciclopirox

    CICLOPIROX Teva Pharma GmbH

    TOPICAL FDA: approved

  17. ciclosporin

    APO-CICLOSPORIN Novartis Pharmaceuticals

    EMA: approved · TGA: approved

    S01XA18

  18. cidofovir

    VISTIDE

    INTRAVENOUS FDA: approved · EMA: withdrawn

    J05AB12

  19. cilastatin sodium

    IMIPENEM AND CILASTATIN

    INTRAMUSCULAR FDA: approved

  20. cilostazol

    CILOSTAZOL Teva Pharma GmbH

    ORAL FDA: approved

  21. ciltacabtagene autoleucel

    CARVYKTI

    EMA: approved

    L01XL05

  22. cimetidine

    CIMETIDINE BICYCLE THERAPEUTICS

    ORAL FDA: approved

  23. cimetidine hydrochloride

    TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER BICYCLE THERAPEUTICS

    INJECTION FDA: approved

  24. cinacalcet

    CINACALCET VIATRIS Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    H05BX01

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources